Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 282.00
-0.90 (-0.32%)
Sep 18, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 19.21 billion as of September 18, 2026. Its market cap has decreased by -36.71% in one year.
Market Cap
19.21B
Enterprise Value
5.16B
Revenue
4.64B
Ranking
n/a
PE Ratio
7.32
Stock Price
282.00
ChartMarket Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 19.21B, an increase of 1,266.42%. That is a compound annual growth rate of 17.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 19.21B | -41.53% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.24T |
| Genmab | 134.09B |
| Coloplast | 94.59B |
| Demant | 63.10B |
| ALK-Abelló | 44.15B |
| H. Lundbeck | 41.63B |
| Ambu A/S | 17.10B |
| Bavarian Nordic | 15.70B |